Epigenomics AG

Research and Markets: Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative Technologies, Growth Opportunities and the Future Market Outlook.
Business Wire; 12/8/2009; 707 words; ...Inc, * Imgenex Corp , * Illumina Inc, * GenTel BioSciences Inc, * GeneNews Ltd , * ExonHit Therapeutics SA, * Epigenomics AG, * Decision Biomarkers Inc, * Cybrdi Inc, * CombiMatrix Corp , * CapitalBio Corp , * Caliper Life Sciences Inc...

Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative Technologies, Growth Opportunities and the Future Market Outlook.
M2 Presswire; 12/8/2009; 759 words; ...Inc, - Imgenex Corp , - Illumina Inc, - GenTel BioSciences Inc, - GeneNews Ltd , - ExonHit Therapeutics SA, - Epigenomics AG, - Decision Biomarkers Inc, - Cybrdi Inc, - CombiMatrix Corp , - CapitalBio Corp , - Caliper Life Sciences Inc...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2045 words; ...treat a variety of inflammatory diseases and cancers. Epigenomics AG, of Berlin, and Biopsytec Holding AG, also of Berlin, entered a cross-licensing agreement under which Epigenomics gains exclusive rights to use in pharmaceutical research...

AACR Roundup.
BIOWORLD Today; 11/3/2009; 1311 words; ...strongly linked to cancer proliferation and survival. o Epigenomics AG, of Frankfurt, Germany, presented data from its...stage disease (stage I-III, 75 out of 107). Epigenomics now is focusing on streamlining and simplifying the...

German Epigenomics launches colorectal cancer blood test Epi proColon in Europe.
ADP News Germany; 10/6/2009; 772 words; ...molecular diagnostics company Epigenomics AG (ETR:ECX) said today it had...diagnostic (IVD) products, Epigenomics said. In a performance evaluation study, the final step of Epigenomics' IVD product development, analysing...